Moreover, expression of MT1-MMP, was reduced in matrine-treated HPAC cells, suggesting that matrine could be a pancreatic cancer treatment, through WNT-mediated down-regulation of MT1-MMP (Ma et al., 2015). Here, MMP14 is linked to pancreatic neoplasm.